Antacid Market Forecasts from 2021 to 2027 | Latest COVID-19 Impact Analysis | Top Players – Pfizer Inc., Reckitt Benckiser Group Plc, Procter & Gamble

The antacid market is expected to reach US$ 11,666.83 million in 2027 from US$ 8,547.97 million in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027.

The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate. The global antacid market growth is mainly attributed to factors such as increasing prevalence of GERD, and rising prevalence of obesity. However, low awareness associated with gastrointestinal disorders in low-income economies is restricting the Antacid market growth.

Get a sample report of the Antacid Market Report

(* Please let us know if you have special requirements. We will provide the report as needed. )

Some of the companies competing in the Antacid market are

Bayer AG
GlaxoSmithKline plc.
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd
Boehringer Ingelheim International GmbH
Dr. Reddy’s Laboratories
Pfizer Inc.
Reckitt Benckiser Group Plc
Procter & Gamble

Global Antacid Market – by Dosage Form


Global Antacid Market – by Drug Class

Proton pump inhibitors
H2 Antagonist
Acid neutralizers

Global Antacid Market – by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Gastroesophageal reflux disease (GERD), a digestive disorder that affects the ring of muscle between esophagus and stomach, is a chronic and highly prevalent disorder. As per the report ‘Update on the epidemiology of gastro-esophageal reflux disease: a systematic review’ published in 2014, the prevalence of GERD is 18.1–27.8% in North America, 2.5–7.8% in East Asia, 8.8–25.9% in Europe, 8.7–33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America.

Regional / Country Antacid Market: North America, Europe, Asia Pacific, Middle East and Africa, Latin America

The research provides answers to the following key questions:

1. What is the estimated growth rate of the market for the forecast period 2021–2028? What will be the market size during the estimated period?
2. What are the key driving forces responsible for shaping the fate of the Antacid market during the forecast period?
3. Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Antacid market?
4. What are the prominent market trends influencing the development of the Antacid market across different regions?
5. What are the major threats and challenges likely to act as a barrier in the growth of the Antacid market?
6. What are the major opportunities the market leaders can rely on to gain success and profitability?

Interested in purchasing this report? Click here @

Thank you for reading this release. You can also customize this report to get coverage for selected chapters and regions in regions such as Asia, North America, and Europe.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876
Email: [email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *